Veradermics, Incorporated: Citigroup raises target price to $175 from $160
MANE•Citigroup raised its target price for Veradermics, Incorporated to $175 from $160.
Related News
Cellectar Biosciences Q3 net loss widens on higher R&D costs
CLRB•
Nvidia CEO's affair with alleged spy reportedly aided $7.5 billion in China chip shipments
NVDA•
Deutsche Bank raises Sarepta Therapeutics to hold from sell, target to $18 from $14
SRPT•
XCharge raises 2026 revenue outlook to $33.2 million-$39.4 million
XCH•
Founder Group swings to net profit of RM 791,785 for six months ended June 30, 2026
FGL•